Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
ANTABIO
🇫🇷
France
Country
🇫🇷
France
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Assessment of the Pharmacokinetics and Safety of ANT3310 Combined With Meropenem in Renally Impaired Subjects
Phase 1
Recruiting
Conditions
Renal Impairment
Interventions
Drug: ANT3310
Drug: Meropenem
Subscribe
First Posted Date
2024-07-30
Last Posted Date
2024-08-21
Lead Sponsor
Antabio
Target Recruit Count
48
Registration Number
NCT06527677
Locations
🇩🇪
CRS Clinical Research Services Kiel GmbH, Kiel, Germany
Subscribe
FiH Study to Assess Safety and PK of SAD and MAD of ANT3310 Alone and in Combination With Meropenem in Healthy Subjects
Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
Drug: ANT3310
Drug: ANT3310-placebo
Drug: Meropenem-placebo
Drug: Meropenem
Subscribe
First Posted Date
2023-06-15
Last Posted Date
2024-03-15
Lead Sponsor
Antabio
Target Recruit Count
72
Registration Number
NCT05905913
Locations
🇫🇷
Biotrial, Rennes, France
Subscribe
Prev
1
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy